BELLEVUE, Wash., Oct. 18, 2022 (GLOBE NEWSWIRE) -- EMulate Therapeutics, a clinical-stage, life sciences, digital therapeutics company developing safe, non-invasive, and highly effective treatments ...
Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...
Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
Who will come up with the killer app for drug discovery, the thing that will make finding new medicines faster, cheaper, and less risky? No one has come close to figuring that out, but a group of ...
The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has formed a strategic partnership with F Hoffman La-Roche AG (Roche) that will use Emulate’s Human Emulation System across R&D programs ...
Emulate, Inc. today announced the company’s launch with a $12 million Series A financing to commercialize a first-in-kind, automated ‘Organs-on-Chips’ platform that mimics human physiology and ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National ...
This article was first published in the May 2016 issue of WIRED magazine. Be the first to read WIRED's articles in print before they're posted online, and get your hands on loads of additional content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results